OpenAI has disclosed that a now-banned account originating in China was using ChatGPT to help design promotional materials and project plans for a social media listening tool. OpenAI says that this ...

IN SOME PARTS of life, you'll need to choose one thing over another. Eating in or going out. Kettlebells or dumbbells. But you don't need to be totally ruled by a binary—and you don't have to choose ...

New Jersey has been doling out millions of dollars in property tax benefits to homeowners and renters. But the tax relief program has changed this year. If you purchase a product or register for an ...

Editorial Note: We earn a commission from partner links on Forbes Advisor. Commissions do not affect our editors' opinions or evaluations. Disclaimer: Calculator results and default inputs are ...

With deer season rolling along, driving at night has become a little more scary as the animals move around. Even if you don’t hit a deer, it can make for some slick maneuvering on the highway to avoid ...

Why it matters: Microsoft wants companies to do more than just encourage AI use among their employees; it wants the tools to become mandatory. To help achieve this goal, Redmond has updated its Viva ...

NATO is weighing up sweeping new air combat rules that could make it far easier for its pilots to shoot down Russian fighter jets amid rising tensions with Moscow. Defence chiefs are in talks over a ...

Welcome to the era of fakery. The widespread use of instant video generators like Sora will bring an end to visuals as proof. By Brian X. Chen Brian X. Chen is The Times’s lead consumer technology ...

The former tour mates appear to be at the centre of showbiz's most prominent and growing feud, thanks to pointed lyrics featuring in Taylor's new album, The Life Of A Showgirl. 'I heard you call me ...

President Trump said he was considering “trade punishment through tariffs” over Spain’s refusal to increase its military spending. By Jason Horowitz For months, Pedro Sánchez, the progressive prime ...

AUSTIN, Texas, Oct. 14, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients ...